In the SURPASS-2 trial, Tirzepatide participants experienced substantial reductions in HbA1c levels and body weight compared to those treated with semaglutide
It is primarily used to treat type 2 diabetes but also has off-label applications for weight loss
patients should be advised to seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : cholelithiasis and cholecystitis have been reported with GLP-1 receptor agonists [11] [22] Diabetic retinopathy complications : particularly in patients with pre-existing retinopathy who experience rapid improvement in glucose control Common adverse effects of Januvia include: Upper respiratory tract infections and nasopharyngitis Headache and gastrointestinal disturbances (though generally milder than with GLP-1 agonists) Rare but serious risks : acute pancreatitis, severe joint pain, hypersensitivity reactions, and bullous pemphigoid (a serious skin condition) When used together, there is a theoretical increased risk of gastrointestinal side effects , particularly nausea, as both medications influence gut hormone pathways
Vegetarian and vegan diets Vitamin b12 comes almost exclusively from animal products
Given these limitations, there is an urgent need for more effective treatments for APAP overdose